drugset / Trial / NCT01520077
Vytorin in the Treatment of Alopecia Areata
NaSingle-groupOpen-labelTreatment
Summary
Subjects, non pregnant/lactating and over 18years old, with 40% alopecia areata will take vytorin (statin/ezetimibe) for 24 or 52 weeks and be monitored for hair regrowth. The investigators hypothesize that Vytorin medication may have an effect on the inflammatory process of alopecia areata. Inactivating the inflammatory process may help in permitting hair regrowth in those subjects.
Timeline
- Start
- 2011-07
- Primary completion
- 2015-01
- Completion
- 2015-01
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | 40 mg | Oral |
| Subject | Simvastatin | Small molecule | 10 mg | Oral |